PARTNERING
If your goal is to develop first-in-class therapies that halt or reverse fibrosis and you seek to leverage a cutting-edge, disease-specific phenotypic platform,
we are ready to collaborate.
Let's harness the full potential of our platform and expand into new therapeutic areas together.
INVESTORS AND FUNDING
3D-FibroScreen raised a pre-seed fund with the participation of Impacthéo, ButterFly Fund and finance&invest.brussels.
The company also received non-dilutive funding from the Walloon Region.